Ask Not for Whom the Bell Tolls, it Tolls for Your LDT (Part I)
On October 3 of this year, the Food and Drug Administration (FDA) published draft guidance documents that, when finalized, will mark a “game changer” for clinical laboratories. Specifically, these guidances call for the active regulation of a subset of in vitro diagnostic devices known as Laboratory Developed Tests (LDTs) and the firms that produce them.
Ask Not for Whom the Bell Tolls, it Tolls for Your LDT (Part I) Read More »













